Literature DB >> 14423207

[Oncolysis experiments with apathogenic, anaerobic spore suspensions on the Ehrlich tumor of the mouse].

J R MOESE, G MOESE.   

Abstract

Entities:  

Keywords:  NEOPLASMS/experimental

Mesh：

Substances：

Year:  1959        PMID： 14423207

Source DB:  PubMed          Journal:  Z Krebsforsch        ISSN： 0301-1585


× No keyword cloud information.
  5 in total

1.  [Effect of celandine alkaloids on the growth of mouse ascites tumor].

Authors:  H WIDMANN
Journal:  Arch Geschwulstforsch       Date:  1955

2.  Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration.

Authors:  R A MALMGREN; C C FLANIGAN
Journal:  Cancer Res       Date:  1955-08       Impact factor: 12.701

3.  Microbiology and cancer therapy; a review.

Authors:  H C REILLY
Journal:  Cancer Res       Date:  1953-12       Impact factor: 12.701

4.  Iron broth, an enrichment medium for anaerobes.

Authors:  K BERGER
Journal:  Wien Med Wochenschr       Date:  1947-09-06

5.  [Methods of quantitative determination of streptomycin and aureomycin].

Authors:  G HENNEBERG; W WATERSTRAAT
Journal:  Zentralbl Bakteriol Orig       Date:  1950-12-29
  5 in total
  7 in total

1.  Enhancement of incorporation of 131iododeoxyuridine into tumors after application of Clostridium oncolyticum s. butyricum (M 55). Animal experiments on positive scintigraphic localization of tumors.

Authors:  M Volm; D Gerick; J Schuhmacher; K Wayss
Journal:  Eur J Nucl Med       Date:  1977-06-30

2.  [Use of tissue extracts in the treatment of cancer].

Authors:  U Mohr
Journal:  Langenbecks Arch Chir       Date:  1971-12

3.  [The influence of ellagic acid on the oncolytic effect of clostridium M55 (author's transl)].

Authors:  J R Möse; G Fischer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

4.  [The effect of non-pathogenic Clostridia on malignant tumors].

Authors:  A Propst; J R Möse
Journal:  Z Krebsforsch       Date:  1966

5.  [Experiments on the serological diagnosis of tumors with sporeforming bacteria (3)].

Authors:  J R Möse; D Gericke
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

6.  Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.

Authors:  Shie-Chau Liu; G-One Ahn; Mitomu Kioi; Mary-Jo Dorie; Adam V Patterson; J Martin Brown
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

7.  Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems.

Authors:  Ming Q Wei; Ruimei Ren; David Good; Jozef Anné
Journal:  Genet Vaccines Ther       Date:  2008-02-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.